跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA KRKA 40 MG/5 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA KRKA 40 MG/5 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA KRKA 40 MG/5 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Krka D.D. Novo Mesto
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jun 15, 2020
Approval ID
e666fad6c0811247
Company
Krka D.D. Novo Mesto
Type
Standard
Approval Details
Approval Id
e666fad6c0811247
Drug Cima Aemps Name
OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA KRKA 40 MG/5 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
85170
Holder Company Name
Krka D.D. Novo Mesto
Marketing Company Name
Krka Farmaceutica S.L.
Authorization Date
2020-06-15
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
40 mg/5 mg/12.5 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Krka D.D. Novo Mesto
Active Ingredients
OLMESARTAN MEDOXOMILO
40 mg
AMLODIPINO BESILATO
6,94 mg
HIDROCLOROTIAZIDA
12,5 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jun 15, 2020
Approval ID
e666fad6c0811247
Type
Standard
Back to CIMA-AEMPS Approvals